New blood tests measuring p-tau217 levels show promise for predicting Alzheimer's risk years before symptoms appear, though ...
WASHINGTON — The blast shook the ground and its red flash of fire covered the doorway as U.S. special operations forces blew open a door during a recent training exercise. Moments later, in their next ...
New research is bringing scientists closer to detecting Alzheimer’s earlier than ever before, raising hopes for timely ...
Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.
Harvard University -affiliated researchers at Mass General Brigham in Boston say that the test for pTau217, an amyloid ...
Scientists from Mass General Brigham have discovered that a blood test may help predict Alzheimer’s disease much earlier than ...
Plasma pTau217 may detect initial buildup of AD-related brain changes before they can be detected by current ‘gold standard’ ...
A new study shows how a blood test measuring pTau217 could predict Alzheimer’s disease years before symptoms manifest, offering a new frontier in early diagnosis and intervention.
By Dennis Thompson HealthDay ReporterWEDNESDAY, April 15, 2026 (HealthDay News) — A blood test can predict Alzheimer’s disease progression in a person’s brain years before they show any symptoms of ...
Boston scientists find blood test can predict disease before symptoms — ‘Trying to push back the clock to enable earlier Alzheimer’s disease prediction’ ...
A new study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results